Literature DB >> 31571695

Vaccine Development and Collaborations: Lessons from the History of the Meningococcal A Vaccine (1969-73).

Baptiste Baylac-Paouly1,2.   

Abstract

Based on a wide range of historical sources, including published scientific literature and archives (Institut Mérieux, WHO and IMTSSA), this article examines the history of the development of the meningococcal A vaccine between 1969 and 1973. It explores the social factors of vaccine development including various collaborations, informal discussions, the circulation of products and materials, formal meetings, trials and setbacks to highlight the complex reality of the development, production and use of the vaccine. Inscribed in a 'Golden Age' of vaccine development and production, this episode not only adds to the scholarship on the history of vaccines, which has tended to focus on a narrative of progress, but also considers the sharing of knowledge through collaborations, and the risks involved in the development of a vaccine. Finally, this perspective reveals the uncertainties and difficulties underlying the production of an effective vaccine.
© The Author 2019.

Keywords:  Africa; Cerebrospinal meningitis A; Collaborations; Institut Mérieux; Meningococcal vaccine; World Health Organization

Year:  2019        PMID: 31571695      PMCID: PMC6733771          DOI: 10.1017/mdh.2019.43

Source DB:  PubMed          Journal:  Med Hist        ISSN: 0025-7273            Impact factor:   1.419


  20 in total

1.  [General medical officer Lapeyssonnie "the man of big endemics"].

Authors:  J Dutertre
Journal:  Bull Soc Pathol Exot       Date:  2002-12

2.  [The basis of antimeningococcic prophylaxis].

Authors:  R Faucon
Journal:  Med Trop (Mars)       Date:  1968 Mar-Apr

3.  [A practical epidemiological problem in the Sahel region of Africa: detection of rhinopharyngeal carriers of Meningococcus].

Authors:  P Ghipponi; J Darrigol; R Faucon
Journal:  Med Trop (Mars)       Date:  1968 Jul-Aug

4.  Current status of prophylaxis of meningococcal disease.

Authors:  M S Artenstein; R Gold
Journal:  Mil Med       Date:  1970-09       Impact factor: 1.437

Review 5.  Critical episodes in the understanding and control of epidemic meningococcal meningitis.

Authors:  Andrew W Artenstein; F Marc LaForce
Journal:  Vaccine       Date:  2012-04-21       Impact factor: 3.641

Review 6.  [Which vaccination strategies for African meningococcal meningitis?].

Authors:  P Saliou; H Debois
Journal:  Bull Soc Pathol Exot       Date:  2002-12

7.  A controlled field trial of a serogroup A meningococcal polysaccharide vaccine.

Authors:  M H Wahdan; F Rizk; A M el-Akkad; A A el-Ghoroury; R Hablas; N I Girgis; A Amer; W Boctar; J E Sippel; E C Gotschlich; R Triau; W R Sanborn; B Cvjetanović
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

8.  Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Ambiguous Capture: Collaborative Capitalism and the Meningitis Vaccine Project.

Authors:  Janice Graham
Journal:  Med Anthropol       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.